The U.S. Centers for Disease Control and Prevention has accepted its advisory panel's recommendations on vaccines for ...

The U.S. Centers for Disease Control and Prevention accepted its advisory panel's recommendations on vaccines for chikungunya ...

The CDC began recommending Ixchiq last year for adults traveling to countries where chikungunya is common. The vaccine uses a ...

The FDA and CDC are recommending a pause on the use of Ixchiq (chikungunya vaccine, live) in patients 60 years and older during an ongoing safety investigation.

The decision follows ongoing investigations into serious adverse events primarily reported in elderly individuals who ...

The FDA and CDC recommended a pause for Ixchiq, a chikungunya vaccine, following reports of adverse events in recipients 60 ...

The recommendations were approved on May 13, 2025, and are now the official recommendations of the CDC. The final recommendations ... Valneva make vaccines for chikungunya.